Internal tandem duplication (ITD) of sequences in the juxtamembrane domain is the most prevalent genetic aberration of FLT3, with a gain of function mutation, implicated in 20-30% of AML patients [5, 7–10]. This evidence concerns the gene FLT3 and acute myeloid leukemia.